Alcoholic Hepatitis Treatment Global Market Report 2025
상품코드:1824325
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
알코올성 간염 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.8%를 나타내 47억 9,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 새로운 치료법이나 의약품 파이프라인, 정밀의료 접근법, 질환 병인의 이해의 깊어짐, 간의 건강에 대한 주목의 높아짐, 알코올 남용에 대처하는 공중 보건 정책 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 맞춤형 의료 접근법, 간 이식 동향, 원격 의료 및 원격 모니터링, 공동 연구 이니셔티브, 혁신적인 약물 솔루션 등이 있습니다.
향후 5년간의 성장률 8.8%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 인도와 독일에서 수입되는 부신피질 스테로이드 제제 및 간기능 보조기구의 비용을 증가시키고, 급성기 치료의 결과를 악화시키고, 소화기과의 비용을 증가시킬 수 있기 때문에 미국 간 질환 치료를 혼란시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
알코올 섭취와 관련된 간질환의 이환율 증가는 향후 알코올성 간염 치료 시장 성장을 이끌 것으로 예측됩니다. 알코올성 간 질환은 혈액 여과와 소화를 위한 담즙의 생성과 같은 간 기능에 장애가 생기면서 발생합니다. 알코올성 간염 치료는 이 질환을 가진 일부 환자에서 간 염증을 다루는 것을 목표로 합니다. 알코올성 간염이 중증화되면 치료를 위해 입원이 필요할 수 있습니다. 예를 들어, 2024년 4월 영국 정부 기관인 Office for Health Improvement and Disparities가 발표한 데이터에 따르면, 2022년 간 질환에 의한 조기 사망자는 1만 593명으로, 그중 남성이 6,664명, 여성이 3,929명이었습니다. 게다가 2023년 종료된 회계연도에는 잉글랜드에서 간질환에 의한 입원이 8만 5,665건 기록되어, 인구 10만명당 155.2명의 비율이 되었고, 특히 알코올성 간질환에 의한 입원은 2만 7,085건으로, 인구 10만명당 49.4명의 비율에 해당했습니다. 따라서 알코올성 간질환의 유병률 상승은 알코올성 간염 치료 시장 성장을 가속하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 알코올성 간염 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 알코올성 간염 치료 시장 : 성장률 분석
세계의 알코올성 간염 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 알코올성 간염 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 알코올성 간염 치료 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 알코올성 간염 치료 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약물 치료
줄기세포 치료
세계의 알코올성 간염 치료 시장 : 약제 클래스별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드
혈류역학제
단일클론 항체
단백동화 스테로이드
기타 약물 분류
세계의 알코올성 간염 치료 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사제
세계의 알코올성 간염 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
개인 치료 센터
세계의 알코올성 간염 치료 시장 : 약물 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드
펜톡시필린
기타 면역억제제
세계의 알코올성 간염 치료 시장 : 줄기세포 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
자가 줄기세포 치료
동종 줄기세포 치료
제7장 지역별/국가별 분석
세계의 알코올성 간염 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 알코올성 간염 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
알코올성 간염 치료 시장 : 경쟁 구도
알코올성 간염 치료 시장 : 기업 프로파일
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Gilead Sciences Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Johnson & Johnson
GlaxoSmithKline plc
AstraZeneca plc
F. Hoffmann-La Roche Ltd
Sanofi SA
Novartis AG
Amgen Inc.
Eli Lilly and Company
Takeda Pharmaceutical Company Limited
Bayer AG
Boehringer Ingelheim International GmbH
Mallinckrodt Pharmaceuticals
Intercept Pharmaceuticals Inc.
Madrigal Pharmaceuticals, Inc.
Conatus Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
알코올성 간염 치료 시장(2029년) : 새로운 기회를 제공하는 국가
알코올성 간염 치료 시장(2029년) : 새로운 기회를 제공하는 부문
알코올성 간염 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Alcoholic hepatitis treatment involves interventions aimed at promoting abstinence from alcohol and addressing the symptoms of liver damage. The therapeutic approach to alcoholic hepatitis focuses on the cessation of alcohol consumption and the administration of medications to alleviate liver-related symptoms.
The primary modalities of treatment for alcoholic hepatitis include pharmaceutical interventions and stem cell therapy. Pharmaceutical treatment entails the use of medications, excluding food, to prevent, detect, treat, or alleviate the symptoms of diseases or abnormal conditions. Drug classes such as corticosteroids, hemorheologic agents, monoclonal antibodies, anabolic steroids, and others are administered through oral and injectable routes. These treatments are typically provided by healthcare facilities, clinics, and private treatment centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The alcoholic hepatitis treatment market research report is one of a series of new reports from The Business Research Company that provides alcoholic hepatitis treatment market statistics, including alcoholic hepatitis treatment industry global market size, regional shares, competitors with an alcoholic hepatitis treatment market share, detailed alcoholic hepatitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alcoholic hepatitis treatment industry. This alcoholic hepatitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The alcoholic hepatitis treatment market size has grown strongly in recent years. It will grow from $3.2 billion in 2024 to $3.43 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to high prevalence of alcohol abuse, increased awareness and diagnostics, government initiatives on alcoholism, increased healthcare expenditure, public health campaigns.
The alcoholic hepatitis treatment market size is expected to see strong growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging therapies and drug pipeline, precision medicine approaches, growing understanding of disease pathogenesis, increasing focus on liver health, public health policies addressing alcohol abuse. Major trends in the forecast period include personalized medicine approaches, liver transplantation trends, telemedicine and remote monitoring, collaborative research initiatives, innovative drug solutions.
The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. hepatology care by increasing costs for corticosteroid formulations and liver support devices imported from India and Germany, potentially worsening acute care outcomes and raising gastroenterology department expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of liver diseases related to alcohol consumption is anticipated to drive the growth of the alcoholic hepatitis treatment market in the future. Alcoholic liver disease results from damage to the liver's functions, which include filtering blood and producing bile for digestion. Alcoholic hepatitis treatment aims to address liver inflammation in some patients with this condition. Those with severe alcoholic hepatitis may require hospitalization for therapy. For example, in April 2024, data published by the Office for Health Improvement and Disparities, a UK government unit, revealed that there were 10,593 premature deaths from liver disease in 2022, including 6,664 males and 3,929 females. Additionally, the financial year ending in 2023 recorded 85,665 hospital admissions for liver disease in England, translating to a rate of 155.2 per 100,000 population, with 27,085 admissions specifically for alcoholic liver disease, which corresponds to a rate of 49.4 per 100,000 population. Therefore, the rising prevalence of alcohol-related liver diseases is propelling the growth of the alcoholic hepatitis treatment market.
The increasing emphasis on personalized medicine is expected to further boost the growth of the alcoholic hepatitis treatment market. Personalized medicine is a groundbreaking approach to medical treatment and healthcare that considers individual variations in patients' genes, environments, and lifestyles. This approach enables customized treatment plans, identification of susceptibility factors, optimization of medication selection, tailored therapies, individualized risk assessment, and a reduction in adverse effects, ultimately enhancing patient engagement and compliance with treatment plans. For instance, in February 2023, a report from the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that personalized medicines represented 35% of newly approved New Molecular Entities (NMEs) in 2021, with 12 new approvals in 2022, maintaining a consistent share of at least 25% of new drug approvals over the past eight years-a significant rise from under 10% a decade ago. Therefore, the growing focus on personalized medicine is driving the growth of the alcoholic hepatitis treatment market.
Product innovation stands as a prominent and increasingly adopted trend within the alcoholic hepatitis treatment market. Companies engaged in this sector are placing significant emphasis on pioneering new products to maintain their competitive edge. An illustrative example is the July 2022 release by Roche Holding AG of the Elecsys HCV Duo, a groundbreaking dual antibody and antigen diagnostic test for hepatitis C virus (HCV). This innovative test enables independent and simultaneous detection of HCV antigen and antibody status using a single human plasma or serum sample. It aids in identifying patients in recovery or exhibiting chronic infection symptoms that might lead to conditions such as liver cancer or early-stage infections. The early manifestation of HCV's core antigen during infection, utilized as an indicator of ongoing viral replication, enables physicians to diagnose active HCV at an earlier stage compared to using solely antibody assays, enhancing diagnostic capabilities.
Prominent entities in the alcoholic hepatitis treatment market are channeling their efforts towards product development, specifically focusing on immunoassays, as a strategic driver for revenue generation. Immunoassays represent a type of biochemical testing method leveraging antibodies' specific binding to antigens to detect and quantify the presence or concentration of a target molecule (analyte) in a sample. For instance, in November 2023, F. Hoffmann-La Roche Ltd. unveiled Elecsys HBeAg quant, an immunoassay designed to measure hepatitis B e antigen (HBeAg) levels in human serum and plasma in both qualitative and quantitative formats. It serves as a predictive tool for chronic active hepatitis and an early indicator of acute hepatitis B infection. This test aids in diagnosing and monitoring individuals with hepatitis B virus infection when complemented with supplementary laboratory findings and clinical data. The Elecsys HBeAg quant, compatible with Roche's Cobas e analyzers, is intended for use with samples from patients with known positive results as well as those with an undetermined HBeAg status.
In October 2022, the France-based biotechnology company Genfit completed the acquisition of Versantis AG for an undisclosed amount. This strategic move enhances GENFIT's leadership position in acute-on-chronic liver failure (ACLF) and significantly broadens its pipeline. The acquisition brings valuable assets to GENFIT's portfolio, including VS-01-ACLF, a Phase 2-ready program based on first-in-class scavenging liposomes technology, VS-01-UCD, a pediatric program targeting urea cycle disorder (UCD), and VS-02-HE, an early-stage program focusing on hepatic encephalopathy (HE). Versantis AG, based in Switzerland, is a biotech company specializing in the development of therapeutics for hepatitis and alcohol-related liver diseases.
Major companies operating in the alcoholic hepatitis treatment market include AbbVie Inc., Gilead Sciences Inc., Bristol-Myers Squibb Company, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, F. Hoffmann-La Roche Ltd, Sanofi S.A., Novartis AG, Amgen Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim International GmbH, Mallinckrodt Pharmaceuticals, Intercept Pharmaceuticals Inc., Madrigal Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., DURECT Corporation, Viking Therapeutics Inc., CymaBay Therapeutics Inc., Genfit SA, BioVie Inc., Akero Therapeutics Inc., Zydus Cadila, Dr. Reddy's Laboratories Ltd.
North America was the largest region in the alcoholic hepatitis treatment market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the alcoholic hepatitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The alcoholic hepatitis treatment market consists of revenues earned by entities by providing infection surveillance, ulcer prophylaxis, and liver transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The alcoholic hepatitis treatment market also includes sales of anti-inflammatory medication such as steroids, pentoxifylline, and glucocorticoids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Alcoholic Hepatitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on alcoholic hepatitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for alcoholic hepatitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alcoholic hepatitis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Drug Treatment; Stem Cell Therapy
2) By Drug Class: Corticosteroids; Hemorheologic Agents; Monoclonal Antibodies; Anabolic Steroids; Other Drug Classes
3) By Route Of Administration: Oral; Injectable
4) By Application: Hospital; Clinic; Private Treatment Center
Subsegments:
1) By Drug Treatment: Corticosteroids; Pentoxifylline; Other Immunosuppressants
3. Alcoholic Hepatitis Treatment Market Trends And Strategies
4. Alcoholic Hepatitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Alcoholic Hepatitis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Alcoholic Hepatitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Alcoholic Hepatitis Treatment Market Growth Rate Analysis
5.4. Global Alcoholic Hepatitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Alcoholic Hepatitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Alcoholic Hepatitis Treatment Total Addressable Market (TAM)
6.1. Global Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Treatment
Stem Cell Therapy
6.2. Global Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Hemorheologic Agents
Monoclonal Antibodies
Anabolic Steroids
Other Drug Classes
6.3. Global Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
6.4. Global Alcoholic Hepatitis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinic
Private Treatment Center
6.5. Global Alcoholic Hepatitis Treatment Market, Sub-Segmentation Of Drug Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Pentoxifylline
Other Immunosuppressants
6.6. Global Alcoholic Hepatitis Treatment Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Stem Cell Therapy
Allogeneic Stem Cell Therapy
7. Alcoholic Hepatitis Treatment Market Regional And Country Analysis
7.1. Global Alcoholic Hepatitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Alcoholic Hepatitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Alcoholic Hepatitis Treatment Market
9.1. China Alcoholic Hepatitis Treatment Market Overview
9.2. China Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Alcoholic Hepatitis Treatment Market
10.1. India Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Alcoholic Hepatitis Treatment Market
11.1. Japan Alcoholic Hepatitis Treatment Market Overview
11.2. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Alcoholic Hepatitis Treatment Market
12.1. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Alcoholic Hepatitis Treatment Market
13.1. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Alcoholic Hepatitis Treatment Market
14.1. South Korea Alcoholic Hepatitis Treatment Market Overview
14.2. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Alcoholic Hepatitis Treatment Market
15.1. Western Europe Alcoholic Hepatitis Treatment Market Overview
15.2. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Alcoholic Hepatitis Treatment Market
16.1. UK Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Alcoholic Hepatitis Treatment Market
17.1. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Alcoholic Hepatitis Treatment Market
18.1. France Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Alcoholic Hepatitis Treatment Market
19.1. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Alcoholic Hepatitis Treatment Market
20.1. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Alcoholic Hepatitis Treatment Market
21.1. Eastern Europe Alcoholic Hepatitis Treatment Market Overview
21.2. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Alcoholic Hepatitis Treatment Market
22.1. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Alcoholic Hepatitis Treatment Market
23.1. North America Alcoholic Hepatitis Treatment Market Overview
23.2. North America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Alcoholic Hepatitis Treatment Market
24.1. USA Alcoholic Hepatitis Treatment Market Overview
24.2. USA Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Alcoholic Hepatitis Treatment Market
26.1. South America Alcoholic Hepatitis Treatment Market Overview
26.2. South America Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Alcoholic Hepatitis Treatment Market
27.1. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Alcoholic Hepatitis Treatment Market
28.1. Middle East Alcoholic Hepatitis Treatment Market Overview
28.2. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Alcoholic Hepatitis Treatment Market
29.1. Africa Alcoholic Hepatitis Treatment Market Overview
29.2. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Alcoholic Hepatitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Alcoholic Hepatitis Treatment Market Competitive Landscape And Company Profiles
